Effect of age and gender on pharmacokinetics and pharmacodynamics of a single ticagrelor dose in healthy individuals


The aim of this study was to assess age and gender effects on ticagrelor pharmacokinetics and pharmacodynamics (PK/PD). Forty healthy individuals [18–45 years (young); ≥65 years (elderly); ten men, ten women per age group) received 200 mg ticagrelor. Ticagrelor was rapidly absorbed [time to maximum concentration (Cmax) (tmax) 2.5–3.0 h], and its major… (More)
DOI: 10.1007/s00228-012-1227-4

6 Figures and Tables


  • Presentations referencing similar topics